The Twincretin Peak: Why Researchers are Sourcing GLP-2 TRZ (Tirzepatide) in 2026In the rapid evolution of metabolic medicine, 2026 has been defined by the move away from single-receptor molecules. While the early 2020s belonged to GLP-1, the current standard for maximal metabolic intervention is GLP-2 TRZ—known clinically as Tirzepatide.By actin